An interesting investigation that assesses the beneficial effects of high-dose atorvastatin in preventing contrast-induced nephropathy in patients receiving non-urgent cardiac catheterization.







**************************************

Estimated Time to View: 50 minutes
Title: Statin use for renoprotection against contrast-induced nephropathy
Author: Sarath Kolluru, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2011
Date Created: 2011
Revisions: None Indicated
Disclaimers: None
Resource Type: Video
Other: Presented at ECU Nephrology Journal Club on 11/15/11
Recommend to a Colleague/Friend

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this video using an iPad or iPhone, see below




Transparent Peer Review



GD Star Rating
loading...



To learn more about our 6-point transparent peer review system, click here



Statin use for renoprotection against contrast-induced nephropathy - the ARMYDA-CIN trial, 5.5 out of 10 based on 2 ratings
Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in Miscellaneous (10 of 17 articles)